| Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend)  |
| CACNA1S |
calcium channel, voltage-dependent, L type, alpha 1S subunit |
1q32 |
1(0/1/0)
|
| EGFR |
epidermal growth factor receptor |
7p12 |
1(0/0/1)
|
| MAPK10 |
mitogen-activated protein kinase 10 |
4q22-q23 |
1(0/1/0)
|
| HSPA1A |
heat shock 70kDa protein 1A |
6p21.3 |
2(2/0/0)
|
| CACNA1B |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
9q34 |
1(1/0/0)
|
| PPP3CC |
protein phosphatase 3, catalytic subunit, gamma isozyme |
8p21.3 |
1(0/1/0)
|
| CACNG5 |
calcium channel, voltage-dependent, gamma subunit 5 |
17q24 |
2(1/1/0)
|
| RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
7p22 |
1(1/0/0)
|
| CACNG1 |
calcium channel, voltage-dependent, gamma subunit 1 |
17q24 |
1(0/1/0)
|
| CACNA2D4 |
calcium channel, voltage-dependent, alpha 2/delta subunit 4 |
12p13.33 |
1(1/0/0)
|
| AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
14q32.33 |
3(3/0/0)
|
| CDC25B |
cell division cycle 25B |
20p13 |
1(0/1/0)
|
| PLA2G1B |
phospholipase A2, group IB (pancreas) |
12q24.31 |
4(1/3/0)
|
| CACNB2 |
calcium channel, voltage-dependent, beta 2 subunit |
10p12 |
3(2/1/0)
|
| ARRB2 |
arrestin, beta 2 |
17p13 |
1(1/0/0)
|
| BDNF |
brain-derived neurotrophic factor |
11p14.1 |
37(24/12/1)
|
| CACNG2 |
calcium channel, voltage-dependent, gamma subunit 2 |
22q13.1 |
3(3/0/0)
|
| RASGRF2 |
Ras protein-specific guanine nucleotide-releasing factor 2 |
5q13 |
1(0/0/1)
|
| GNA12 |
guanine nucleotide binding protein (G protein) alpha 12 |
7p22.3 |
1(1/0/0)
|
| PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
1p36.1 |
1(0/1/0)
|
| DUSP6 |
dual specificity phosphatase 6 |
12q22-q23 |
5(3/2/0)
|
| FGF12 |
fibroblast growth factor 12 |
3q28 |
1(0/1/0)
|
| CACNB3 |
calcium channel, voltage-dependent, beta 3 subunit |
12q13 |
1(0/0/1)
|
| PLA2G6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
22q13.1 |
2(1/1/0)
|
| IL1B |
interleukin 1, beta |
2q14 |
1(1/0/0)
|
| CACNA1D |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
3p14.3 |
1(1/0/0)
|
| ATF4 |
activating transcription factor 4 |
22q13.1 |
1(1/0/0)
|
| CACNA2D1 |
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
7q21-q22 |
2(0/0/2)
|
| CACNA1E |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
1q25.3 |
1(1/0/0)
|
| NF1 |
neurofibromin 1 |
17q11.2 |
1(1/0/0)
|
| CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
12p13.3 |
20(17/3/0)
|
| TAOK2 |
TAO kinase 2 |
16p11.2 |
1(0/1/0)
|
| NGF |
nerve growth factor (beta polypeptide) |
1p13.1 |
2(1/1/0)
|
| TNF |
tumor necrosis factor |
6p21.3 |
4(2/2/0)
|
| PPP3CB |
protein phosphatase 3, catalytic subunit, beta isozyme |
10q22.2 |
2(1/1/0)
|
| MAP2K6 |
mitogen-activated protein kinase kinase 6 |
17q |
1(0/1/0)
|
| MAPK8IP2 |
mitogen-activated protein kinase 8 interacting protein 2 |
22q13.33 |
1(0/1/0)
|
| FGFR2 |
fibroblast growth factor receptor 2 |
10q25.3-q26 |
2(1/1/0)
|
| NTRK2 |
neurotrophic tyrosine kinase, receptor, type 2 |
9q22.1 |
3(1/1/1)
|
Basic Info
